Stay updated on TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial
Sign up to get notified when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.

Latest updates to the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe study page loads with a 403 Forbidden message, replacing the trial content with an error page; the header/footer remain, but the study details and links are no longer accessible.SummaryDifference18%

- Check54 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5, indicating an update to the page's version or release notes.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now displays a new revision label, updating from v3.6.4 to v3.6.5 to reflect a software release.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4. This indicates an incremental update to the study record’s documentation rather than any substantive content change.SummaryDifference0.1%

Stay in the know with updates to TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.